ClinicalTrials.gov
public full text
Public Domain
Pharmaco-metabolomic Effects of Statins: METASTATINE
Statins are effective in cardio-vascular prevention by lowering LDL-Cholesterol levels but also through other mechanisms poorly understood. Our hypothesis is that some of these effects are mediated by microbiota alteration, leading to diminution of expression of microbiota derived pro-atherogenic metabolites.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evidence review for statins: efficacy and adverse effects: Cardiovascular disease: risk assessment and reduction, including lipid modification: Evidence review C#2214
- Effect of Probiotics on Cardiometabolic Health#834599
- LIFESTAT - Living With Statins, a Cross Sectional Study#968966
- A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins#846835
- Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)#848531
Record · ID 993577
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive